IL13 and tuberculosis: This study provides new information on host immune responses throughout the course of anti-TB treatment, and enables the identification of a plasma protein signature, composed of C1q and IL-13-specific response to rmsHBHA, capable of differentiating an active form of pulmonary TB from cured disease.